Matches in Wikidata for { <http://www.wikidata.org/entity/Q88213269> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q88213269 description "article scientifique publié en 2018" @default.
- Q88213269 description "artículu científicu espublizáu en marzu de 2018" @default.
- Q88213269 description "scientific article published on 29 March 2018" @default.
- Q88213269 description "wetenschappelijk artikel" @default.
- Q88213269 description "наукова стаття, опублікована 29 березня 2018" @default.
- Q88213269 name "Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy" @default.
- Q88213269 name "Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy" @default.
- Q88213269 type Item @default.
- Q88213269 label "Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy" @default.
- Q88213269 label "Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy" @default.
- Q88213269 prefLabel "Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy" @default.
- Q88213269 prefLabel "Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy" @default.
- Q88213269 P1433 Q88213269-ADDFB5C6-EFF7-45ED-B64E-46C5B8048190 @default.
- Q88213269 P1476 Q88213269-C8E13BF3-EEC1-4C95-ABE1-589DF75A0F26 @default.
- Q88213269 P2093 Q88213269-155C4B66-F3BF-4DB6-8DCB-2B355929BE48 @default.
- Q88213269 P2093 Q88213269-2480DF93-C095-4FD9-B628-5DA79F6A2700 @default.
- Q88213269 P2093 Q88213269-B2C5E198-ECC1-46D6-A341-CF36FA7A06F6 @default.
- Q88213269 P2093 Q88213269-F7D4925C-BDBC-4038-8E37-765BD9359CFB @default.
- Q88213269 P304 Q88213269-AD389267-5F97-4C14-9114-3D1FE64EE41B @default.
- Q88213269 P31 Q88213269-460A3E1B-AB3D-4796-B0B8-514CC5720E99 @default.
- Q88213269 P356 Q88213269-4FE80247-86DD-4D09-9A13-F93C4911CD04 @default.
- Q88213269 P433 Q88213269-9F4B3B7E-C88B-4EF0-AE1D-88A35F9D34FB @default.
- Q88213269 P478 Q88213269-7942FDF1-DD33-45AB-A100-A7F5050E4F67 @default.
- Q88213269 P50 Q88213269-E73B2D0D-1401-4E83-B0AF-7E2EC2074DDE @default.
- Q88213269 P577 Q88213269-54705BE3-14B8-4DE2-84E7-4686035DCDBF @default.
- Q88213269 P698 Q88213269-E216AF27-200A-4E42-8A0D-6D2BE3FEE2A2 @default.
- Q88213269 P921 Q88213269-8A5F9F91-3DCB-44E0-81E8-5694100F84A5 @default.
- Q88213269 P356 00325481.2018.1440873 @default.
- Q88213269 P698 29596012 @default.
- Q88213269 P1433 Q7234297 @default.
- Q88213269 P1476 "Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy" @default.
- Q88213269 P2093 "Alan S Maisel" @default.
- Q88213269 P2093 "Lori B Daniels" @default.
- Q88213269 P2093 "Peter A McCullough" @default.
- Q88213269 P2093 "Sheryl L Chow" @default.
- Q88213269 P304 "299-307" @default.
- Q88213269 P31 Q13442814 @default.
- Q88213269 P356 "10.1080/00325481.2018.1440873" @default.
- Q88213269 P433 "3" @default.
- Q88213269 P478 "130" @default.
- Q88213269 P50 Q64438206 @default.
- Q88213269 P577 "2018-03-29T00:00:00Z" @default.
- Q88213269 P698 "29596012" @default.
- Q88213269 P921 Q181754 @default.